Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(10%)
Results Posted
29%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph early_phase_1
1
10%
Ph phase_2
2
20%
Ph not_applicable
4
40%
Ph phase_3
1
10%
Ph phase_4
1
10%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Active, not recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A4 (44.4%)

Trials by Status

active_not_recruiting110%
completed770%
unknown110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10